Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong · Delayed Price · Currency is HKD 25.68
+0.74 (2.97%)
Last updated: May 27, 2026, 3:59 PM HKT
HKG:2659 Market Cap
HKG:2659 has a market cap or net worth of 8.13 billion as of May 27, 2026.
Market Cap
8.13B
Enterprise Value
7.10B
Revenue
54.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.68
Market Cap Chart
Since December 10, 2025, HKG:2659's market cap has decreased from 20.54B to 8.13B, a decrease of -60.41%. That is a compound annual growth rate of -86.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 8.13B | -67.84% |
| Dec 31, 2025 | 25.28B | 23.10% |
| Dec 10, 2025 | 20.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 11.17B |
| HBM Holdings | 10.54B |
| CARsgen Therapeutics Holdings | 9.43B |
| Alphamab Oncology | 9.06B |
| Shanghai Haohai Biological Technology | 8.35B |
| Lepu Biopharma | 8.26B |
| Abbisko Cayman | 7.34B |
| CK Life Sciences Int'l., (Holdings) | 6.82B |